“Armolipid Plus is indicated for cholesterol control, quickly regulating its level, preventing its accumulation in the arteries, with the aim of preventing and preventing the manifestation of cardiovascular diseases.
Armolipid Plus Properties
Fermented red rice (Monascus purpureus) contains monacolin K, a catalytic chemical structure belonging to the class of statins that participate in cholesterol metabolism.
Berberis aristata helps control cholesterol and triglyceride levels in plasma, contributing to the normalization of cardiovascular functions.
Policosanol is a mixture of natural fatty alcohols contained in a waxy matrix of sugar cane, rice bran and beeswax.
Folic acid contributes to the normal metabolism of homocysteine, which, if it does not work properly, can cause damage to the cardiovascular system. Armolipid Plus satisfies the physiological daily requirement for folic acid
Coenzyme Q10 is involved in oxidation-reduction reactions involved in the synthesis of ATP (adenosine triphosphate).
Astaxanthin is a substance that plays an important role in oxidation-reduction reactions.
Ingredients contained in Armolipid Plus
Armolipid Plus consists of: Berberis aristata es (berberine chloride), fermented red rice (monacolin K), policosanol, folic acid, coenzyme Q10, astaxanthin.
Does not contain gluten.
How to use Armolipid Plus
It is recommended to take one tablet per day orally, unless otherwise recommended by a doctor. If you have difficulty swallowing, it is recommended to break the tablet and make it easier to take by washing it down with a glass of water.
Warnings before using the supplement
It is not recommended to exceed the daily dose recommended by a doctor. Always keep out of reach of children under 3 years of age. Do not use Armolipid Plus under any circumstances during pregnancy and lactation or in case of lipid-lowering therapy.”
Купить Meda Pharma,ArmoLipid Plus 30
Цена Meda Pharma,ArmoLipid Plus 30
Buy Meda Pharma,ArmoLipid Plus 30
Price Meda Pharma,ArmoLipid Plus 30
Reviews
There are no reviews yet.